Skip to Content

Revvity (RVTY US)

RVTY US$152.43

20 minute delayed

Today ▲ 3.14%
1 year return ▲ 67.40%
Volume 253,183
Div yield 0.19%
PE ratio 68.05
52 week range
81.23 171.66

14 days free access

Join Market Matters and get full access to all our Opinion + Action

Learn more

Performance

Advanced charting functionality with the ability to amend timeframes, chart type & indicator selection, powered by TradingView.

Share price activity

Displays share price activity. Volume = number of shares traded, Turnover = value of shares traded, VWAP = volume-weighted average price for the day, sourced from Morningstar.
Last (Price)
152.43
Change
▲ 4.64 (3.14)
Bid / Ask
152.43 - 152.51
Volume
253,183
Turnover
31,809,207
Open
146.66
Day Range
146.66 - 153.06
VWAP
152.07
Prev Close
147.79
Last Trade
18/11 7:00pm
Displays useful ratios for the security, NB the pricing date used, sourced from Morningstar.
Ratios
Currency (Price/reporting): USD/USD
Exchange Rate: 1.0000
Price, volume and trading statistics for the security, sourced from Morningstar.
Price - closing or last bid 147.79
Price - 12 month high 171.66
Price - 12 month low 81.23
Pricing date 17 NOV 2026
Volume - avg. trading volume for the last ten days 1.85
Market capitalization 17,017.10
12 Month High price date 3 NOV 2026
12 Month Low price date 29 APR 2026
Volume - avg. trading volume for the last 3 months 1.92
Price - 1 Day % Change -0.71%
Price - 13 week price percent change 27.22%
Price - 26 week price percent change 57.27%
Price - 5 Day % Change -7.11%
Price - 52 week price percent change 62.30%
Price - YTD price percent change 51.69%
Price % Change Month To Date -3.18%
Earnings, dividends, cash flow and book value per share, sourced from Morningstar.
EPS excluding extraordinary items - most recent fiscal year 2.060
EPS excluding extraordinary items - trailing 12 month 2.250
EPS Normalized - most recent fiscal year 5.060
Revenue/share - most recent fiscal year 24.495
Revenue/share - trailing 12 month 26.238
Book value per share - most recent fiscal year 64.573
Book value per share - most recent quarter 65.161
Book value (tangible) per share - most recent fiscal year -15.231
Book value (tangible) per share - most recent quarter -13.036
Cash per share - most recent fiscal year 8.192
Cash per share - most recent quarter 5.312
Cash Flow per share - most recent fiscal year 5.881
Cash Flow per share - trailing 12 month 6.775
Dividend per share - most recent fiscal year 0.280
Dividends per share - trailing 12 month 0.280
EBITD per share - trailing 12 month 6.841
EPS Basic excluding extraordinary items - most recent fiscal year 2.060
EPS Basic excluding extraordinary items - trailing 12 month 2.250
EPS including extraordinary items - most recent fiscal year 2.070
EPS including extraordinary items - trailing 12 month 2.250
Free Cash Flow per share - trailing 12 month 6.192
Valuation multiples such as P/E, price to sales, price to book and enterprise value ratios, sourced from Morningstar.
P/E excluding extraordinary items, most recent fiscal year 67.75
P/E Normalized, most recent fiscal year 27.46
Price to sales - most recent fiscal year 5.81
Price to Tangible Book - most fiscal year —
Price to Free Cash Flow per Share - most recent fiscal year 24.62
Price to Cash Flow per share - trailing 12 month 22.50
Price to Book - most recent fiscal year 2.34
P/E excluding extraordinary items high, trailing 12 months 79.32
P/E excluding extraordinary items low, trailing 12 months 39.93
Net Debt, LFI 2,172.23
Net Debt, LFY 2,478.35
Dividend Yield - 5 Year Average 0.23%
Dividend Yield - indicated annual dividend divided by closing price 0.19%
Current Dividend Yield - Common Stock Primary Issue, LTM 0.18%
Cash flow, liquidity and leverage measures, sourced from Morningstar.
Free Cash Flow - most recent fiscal year 612.22
LT debt/equity - most recent fiscal year 38.33%
Payout ratio - most recent fiscal year 13.53%
Total debt/total equity - most recent fiscal year 46.87%
LT debt/equity - most recent quarter 38.03%
Total debt/total equity - most recent quarter 38.03%
Free Cash Flow - trailing 12 month 694.23
Payout ratio - trailing 12 month 12.44%
Key income statement lines for the most recent fiscal year, in millions, sourced from Morningstar.
Revenue - most recent fiscal year 2,856.05
Revenue - trailing 12 month 2,941.76
EBITD - most recent fiscal year 734.76
EBITD - trailing 12 month 767.03
Earnings before taxes - most recent fiscal year 268.28
Earnings before taxes - trailing 12 month 282.77
Net Income available to common - most recent fiscal year 241.20
Net Income available to common - trailing 12 months 253.20
Earnings before taxes Normalized - most recent fiscal year 307.64
Net Income Available to Common, Normalized - most recent fiscal year —
Earnings per Share, Normalized, Excluding Extraordinary Items, Avg. Diluted Shares Outstanding, TTM 5.55
Profitability margins for the most recent fiscal year, sourced from Morningstar.
Net Profit Margin % - 1st historical fiscal year 8.40%
Net Profit Margin % - trailing 12 month 8.59%
Operating margin - 1st historical fiscal year 12.49%
Operating margin - trailing 12 month 12.65%
Pretax margin - trailing 12 month 9.61%
Pretax margin - 1st historical fiscal year 9.39%
Operating Margin - 5 year average 18.26%
Pretax Margin - 5 year average 15.73%
Free Operating Cash Flow/Revenue, 5 Year Average 22.71%
Free Operating Cash Flow/Revenue, TTM 23.60%
Net Profit Margin - 5 year average 12.78%
Returns on average assets and equity for the fiscal year, the trailing 12 months and as 5 year averages, and net income and revenue per employee in whole currency, sourced from Morningstar.
Return on average assets - most recent fiscal year 1.95%
Return on average assets - trailing 12 month 2.11%
Return on average equity - most recent fiscal year 3.20%
Return on average equity - trailing 12 month 3.48%
Return on average assets - 5 year average 2.72%
Return on average equity - 5 year average 5.16%
Net Income/employee - most recent fiscal year 21,807.55
Revenue/employee - most recent fiscal year 259,641.00
Growth in revenue, earnings, dividends and book value over recent periods, sourced from Morningstar.
Revenue growth rate, 5 year 1.41%
EPS growth rate, 5 year -20.43%
Growth rate% - dividend, 3 year 0.00%
Revenue/share (5 yr growth) 0.61%
Growth rate% - Revenue, 3 year -4.82%
Growth rate% - EPS, 3 year -22.81%
Book value per share growth rate, 5 year 14.12%
Capital Spending growth rate, 5 year 2.93%
Earnings Before Interest, Taxes, Depreciation & Amortization, 5 Year CAGR -6.90%
Displays analyst’s forecasts for key measures. The estimates can be expanded to see the spread of the calls. Full lines = reported, and dotted lines are forward estimates. Click a measure to add or remove it from the chart, sourced from Morningstar.

Financial forecast (USD, millions except per share)

Actuals Estimates
2025 2026202720282029
Financial metrics can be plotted on the graph to see trends. Multiple metrics from multiple statements can be plotted against each other, sourced from Morningstar.

Financials (USD, millions)

Period end: DEC 21DEC 22DEC 23DEC 24DEC 25
Fiscal year: 20212022202320242025
Period length: 12 months12 months12 months12 months12 months
Displays all company announcements released by the company to the exchange, sourced from Morningstar.

Announcements

Announcements are available for ASX-listed companies only.

Opinion

No opinions for this company yet.

Action

No actions for this company yet.

Business Summary

Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.

image description

Relevant suggested news and content from the site

Back to top